KeifeRx is a biotech company focused on the discovery of disease-modifying treatments for neurodegenerative illnesses.
KeifeRx has raised $6.0M in total funding. The most recent round was Series A. The last funding was announced in December 2021.
KeifeRx is headquartered in Mclean, United States.
KeifeRx is a biotech company focused on the discovery of disease-modifying treatments for neurodegenerative illnesses.
KeifeRx is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"KeifeRx — Funding & Investors." VCBacked, December 8, 2021, https://www.vcbacked.co/company/keiferx. Accessed September 30, 2026.
VCBacked. (2021). KeifeRx — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/keiferx
{{cite web |title=KeifeRx — Funding & Investors |url=https://www.vcbacked.co/company/keiferx |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated